A mecA-Negative Strain of Methicillin-Resistant Staphylococcus aureus with High-Level β-Lactam Resistance Contains Mutations in Three Genes

被引：87

作者：

Banerjee, Ritu ^{[1
]}

Gretes, Michael ^{[2
]}

Harlem, Christopher ^{[3
]}

Basuino, Li ^{[3
]}

Chambers, Henry F. ^{[3
]}

机构：

[1] Mayo Clin, Div Pediat Infect Dis, Rochester, MN 55905 USA

[2] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada

[3] San Francisco Gen Hosp, Div Infect Dis, San Francisco, CA 94110 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2010年 / 54卷 / 11期

关键词：

PENICILLIN-BINDING PROTEINS; STREPTOCOCCUS-PNEUMONIAE; VANCOMYCIN RESISTANCE; ESCHERICHIA-COLI; CEFTOBIPROLE; DOMAIN; PBP4; SUSCEPTIBILITY; EXPRESSION; ACRB;

D O I：

10.1128/AAC.00594-10

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We previously generated a ceftobiprole-resistant Staphylococcus aureus strain after high inoculum serial passage of a mecA-negative variant of strain COL (R. Banerjee, M. Gretes, L. Basuino, N. Strynadka, and H. F. Chambers, Antimicrob. Agents Chemother. 52:2089-2096, 2008). Genome resequencing of this strain, CRB, revealed that it differs from its parent by five single-nucleotide polymorphisms in three genes, specifically, those encoding PBP4, a low-molecular-weight penicillin-binding protein, GdpP, a predicted signaling protein, and AcrB, a cation multidrug efflux transporter. CRB displayed resistance to a variety of beta-lactams but was hypersusceptible to cefoxitin.

引用

页码：4900 / 4902

页数：3

共 29 条

[1] In vitro selection and characterization of ceftobiprole-resistant methicillin-resistant Staphylococcus aureus [J].

Baneriee, Ritu ;

Gretes, Michael ;

Basuino, Li ;

Strynadka, Natalie ;

Charnbers, Henry F. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (06) :2089-2096

[2] Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].

Boucher, Helen W. ;

Talbot, George H. ;

Bradley, John S. ;

Edwards, John E., Jr. ;

Gilbert, David ;

Rice, Louis B. ;

Scheld, Michael ;

Spellberg, Brad ;

Bartlett, John .

CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12

[3] KINETICS OF PENICILLIN-BINDING TO PENICILLIN-BINDING PROTEINS OF STAPHYLOCOCCUS-AUREUS [J].

CHAMBERS, HF ;

SACHDEVA, MJ ;

HACKBARTH, CJ .

BIOCHEMICAL JOURNAL, 1994, 301 :139-144

[4] Targeting the hedgehog pathway to mitigate treatment resistance [J].

Chen, Yu-Jen ;

Sims-Mourtada, Jennifer ;

Izzo, Julie ;

Chao, K. S. Clifford .

CELL CYCLE, 2007, 6 (15) :1826-1830

[5] Activities of ceftobiprole and other β-lactams against Streptococcus pneumoniae clinical isolates from the United States with defined substitutions in penicillin-binding proteins PBP 1a, PBP 2b, and PBP 2x [J].

Davies, TA ;

Shang, WC ;

Bush, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2530-2532

[6] Binding of ceftobiprole and comparators to the penicillin-binding proteins of Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae [J].

Davies, Todd A. ;

Page, Malcolm G. P. ;

Shang, Wenchi ;

Andrew, Ted ;

Kania, Malgosia ;

Bush, Karen .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (07) :2621-2624

[7] Vancomycin Heteroresistance and Methicillin-Resistant Staphylococcus aureus [J].

Deresinski, Stan .

JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (05) :605-609

[8] Single Nucleotide Polymorphism Analysis of the Major Tripartite Multidrug Efflux Pump of Escherichia coli: Functional Conservation in Disparate Animal Reservoirs despite Exposure to Antimicrobial Chemotherapy [J].

Elkins, Christopher A. ;

Mullis, Lisa B. ;

Lacher, David W. ;

Jung, Carina M. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (03) :1007-1015

[9] Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus [J].

Finan, JE ;

Archer, GL ;

Pucci, MJ ;

Climo, MW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) :3070-3075

[10] STAPHYLOCOCCUS-AUREUS PENICILLIN-BINDING PROTEIN-4 AND INTRINSIC BETA-LACTAM RESISTANCE [J].

HENZE, UU ;

BERGERBACHI, B .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2415-2422

← 1 2 3 →